Airway Stents Market Size, Share, and Analysis By Product Type (Expandable Stents [Self-expandable Stents and Balloon-expandable Stents] and Non-expandable Stents), By Type (Laryngeal Stents, Tracheal Stents, and Bronchial Stents), By Material Type (Metal [Nitinol and Stainless Steel], Silicone, and Hybrid), By End-user (Hospitals and ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Airway stents are tube-shaped devices that consist of a hollow lumen. These devices are inserted in an airway to restore airway patency and are utilized by patients with malignant airway strictures and various airway-related diseases. These stents can also be useful in maintaining airway patency after dilatation of post-inflammatory and infectious strictures, for airway dehiscence after lung transplantation, and for the management of tracheobronchomalacia.

The increasing prevalence of airway diseases, such as malignant and non-malignant central airway obstruction, esophageal fistula, and others, have been fueling the demand for airway stents.

• For instance, as per a study published by UpToDate, Inc., a point-of-care medical resource, airway obstruction complicates approximately 20.0% to 30.0% of patients with lung cancer globally.               

Moreover, the increasing launch of innovative airway stents and the increasing focus of key players on mergers and acquisitions have been fueling the market growth.

Impact of COVID-19 on the Airway Stents Market

The global airway stents market experienced a decline in its growth during the COVID-19 pandemic in 2020 due to lockdown restrictions. The decline in the market was due to the lower number of patients visiting hospitals and clinics for non-emergency treatments in order to control the spread of the virus. The increased risk of COVID-19 infection caused by the use of airway stents resulted in the reduced adoption of these stents during the period.

Moreover, due to the lockdown restrictions, the supply chain was also disrupted, resulting in limited product availability in the market.

However, the market grew at a significant growth rate in 2021 and 2022 due to the release of the lockdown restrictions and the increasing emphasis of market players on expanding the availability of their products globally.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Airway Diseases - by Key Countries/Sub-region, 2022/2023
• Pricing Analysis
• Technological Advancements
• Regulatory Scenario for Key Countries/Regions
• Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
• Impact of COVID-19 on the Market

Analysis by Product Type

On the basis of product type, expandable stents accounted for a significant market share in 2023. The segment growth is attributed to the strong focus of key players to launch innovative self-expandable stents for use in various airway disorders

• For instance, in February 2022, MICRO-TECH (Nanjing) Co., Ltd. launched the self-expanding tracheobronchial nitinol y-stent to aid in the treatment of malignant neoplasms at the tracheobronchial carina.

Moreover, the non-expandable stents segment is expected to grow at a substantial CAGR during the forecast period. The segment growth is attributed to the various advantages associated with the non-expandable stents, such as precise stent placement and versatility, which are responsible for the increased adoption of these stents.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America is projected to account for a significant share of the global airway stents market in 2023. The regional market growth is attributed to the strong presence of market players such as MICRO-TECH (Nanjing) Co., Ltd, along with increasing strategies such as partnerships by key players in the market.

• For instance, in July 2022, MICRO-TECH (Nanjing) Co., Ltd, a provider of diagnostic and therapeutic devices, announced a distribution partnership with Thoracent, Inc., an innovator of pulmonary and thoracic products. As per the partnership, Thoracent, Inc. will be the U.S. distributor of Micro-Tech's Y-Shaped Tracheal Stent System, which is designed to aid the management of airway tumors in the trachea without invasive surgery.

Moreover, the Europe market is expected to grow at a significant CAGR during the forecast period. The regional growth is attributed to the focus of market players on launching new products and the increasing prevalence of airway diseases.

Key Players Covered

The report includes the profiles of key players such as Novatech SA, Stening, Boston Scientific Corporation, Getinge, MICRO-TECH (Nanjing) Co., Ltd., Boston Medical Products Inc., TAEWOONG, E. Benson Hood Laboratories, Inc., Merit Medical Systems., ENDO-FLEX GmbH., Standard Sci Tech Inc., Cook, and others.

Key Industry Developments

• In August 2023, Theken Companies, LLC, a family of medical device companies, announced its acquisition of VisionAir Solutions from Cleveland Clinic. The company acquired VisionAir Solutions’s VisionAir 3D Stent Architect, which allows pulmonologists to create personalized silicone stents for patients with symptomatic central airway obstruction.
• In October 2020, Olympus America, a developer of innovative solutions for medical and surgical procedures, launched the HANAROSTENT Esophagus TTS self-expanding metal stents (SEMS) made by M.I. Tech and distributed exclusively through Olympus America in the U.S.